Jan Novák

3.9k total citations · 1 hit paper
63 papers, 1.6k citations indexed

About

Jan Novák is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Jan Novák has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 13 papers in Surgery and 12 papers in Genetics. Recurrent topics in Jan Novák's work include Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (15 papers) and Diabetes and associated disorders (11 papers). Jan Novák is often cited by papers focused on Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (15 papers) and Diabetes and associated disorders (11 papers). Jan Novák collaborates with scholars based in Czechia, United States and France. Jan Novák's co-authors include Agnès Lehuen, Lucie Beaudoin, Lucie Nováková, Thibault Griseri, Tomáš Kozák, Bruno Lucas, Véronique Laloux, Martin Šimkovič, Carol Moreno and Loree Larratt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Novák

57 papers receiving 1.5k citations

Hit Papers

Ibrutinib plus obinutuzum... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
    2018 380 citations Carol Moreno, Richard Greil et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Novák Czechia 19 805 487 440 238 237 63 1.6k
C A Alper United States 21 1.1k 1.4× 521 1.1× 386 0.9× 300 1.3× 277 1.2× 40 2.0k
BR Blazar United States 20 1.1k 1.4× 196 0.4× 259 0.6× 193 0.8× 143 0.6× 38 2.2k
Jean‐Pierre Farcet France 24 595 0.7× 214 0.4× 571 1.3× 178 0.7× 74 0.3× 43 1.4k
J Jansen Netherlands 22 834 1.0× 539 1.1× 325 0.7× 272 1.1× 83 0.4× 65 1.5k
EF Winton United States 16 459 0.6× 159 0.3× 161 0.4× 200 0.8× 95 0.4× 32 1000
Ruud K. B. Schuurman Netherlands 22 1.2k 1.4× 513 1.1× 109 0.2× 353 1.5× 324 1.4× 58 1.6k
Ming‐Ching Shen Taiwan 23 144 0.2× 255 0.5× 211 0.5× 490 2.1× 86 0.4× 91 1.4k
J Tanzer France 23 302 0.4× 446 0.9× 239 0.5× 349 1.5× 196 0.8× 114 1.4k
Nobuyoshi Arima Japan 23 979 1.2× 221 0.5× 157 0.4× 428 1.8× 48 0.2× 88 1.9k
Nathalie Balandraud France 25 536 0.7× 162 0.3× 246 0.6× 318 1.3× 112 0.5× 56 1.8k

Countries citing papers authored by Jan Novák

Since Specialization
Citations

This map shows the geographic impact of Jan Novák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Novák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Novák more than expected).

Fields of papers citing papers by Jan Novák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Novák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Novák. The network helps show where Jan Novák may publish in the future.

Co-authorship network of co-authors of Jan Novák

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Novák. A scholar is included among the top collaborators of Jan Novák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Novák. Jan Novák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novák, Jan, et al.. (2024). Primary ciliary dyskinesia as a rare cause of male infertility: case report and literature overview. Basic and Clinical Andrology. 34(1). 27–27.
2.
Novák, Jan, et al.. (2024). Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies. Scandinavian Journal of Immunology. 99(6). e13364–e13364.
3.
Sekeres, Mikkael A., Pau Montesinos, Jan Novák, et al.. (2023). Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia. 37(10). 2017–2026. 15 indexed citations
4.
Čerňan, Martin, Tomáš Szotkowski, Petr Cetkovský, et al.. (2020). Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. 67(3). 650–659. 3 indexed citations
5.
Moreno, Carol, Richard Greil, Fatih Demırkan, et al.. (2018). Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology. 20(1). 43–56. 380 indexed citations breakdown →
6.
7.
Vydra, Jan, Cyril Šálek, Jiřı́ Schwarz, et al.. (2017). Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission. Clinical Lymphoma Myeloma & Leukemia. 18(2). 106–113. 2 indexed citations
8.
Válková, Veronika, Kateřina Steinerová, Zdeněk Kořı́stek, et al.. (2012). Factors Affecting Quality of Life During and After Stem Cell Transplantation in Long Term Survivors – Comparison of Autologous and Allogeneic Stem Cell Transplantation. Blood. 120(21). 590–590. 1 indexed citations
9.
Mars, Lennart T., Jan Novák, Lucie Beaudoin, et al.. (2008). Invariant NKT Cells Regulate Experimental Autoimmune Encephalomyelitis and Infiltrate the Central Nervous System in a CD1d-Independent Manner. The Journal of Immunology. 181(4). 2321–2329. 52 indexed citations
10.
Novák, Jan, Lucie Beaudoin, Se‐Ho Park, et al.. (2007). Prevention of Type 1 Diabetes by Invariant NKT Cells Is Independent of Peripheral CD1d Expression. The Journal of Immunology. 178(3). 1332–1340. 28 indexed citations
11.
Novák, Jan, Thibault Griseri, Lucie Beaudoin, & Agnès Lehuen. (2007). Regulation of Type 1 Diabetes by NKT Cells. International Reviews of Immunology. 26(1-2). 49–72. 45 indexed citations
12.
Novák, Jan, Lucie Beaudoin, Thibault Griseri, & Agnès Lehuen. (2005). Inhibition of T Cell Differentiation into Effectors by NKT Cells Requires Cell Contacts. The Journal of Immunology. 174(4). 1954–1961. 47 indexed citations
13.
Griseri, Thibault, Lucie Beaudoin, Jan Novák, et al.. (2005). Invariant NKT Cells Exacerbate Type 1 Diabetes Induced by CD8 T Cells. The Journal of Immunology. 175(4). 2091–2101. 28 indexed citations
14.
Novota, Peter, Marie Černá, Katarína Kološtová, et al.. (2004). Diabetes mellitus in adults: association of HLA DRB1 and DQB1 diabetes risk alleles with GADab presence and C-peptide secretion. Immunology Letters. 95(2). 229–232. 4 indexed citations
15.
Babjuk, M., Viktor Soukup, J. Mareš, et al.. (2002). The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome. International Urology and Nephrology. 34(4). 495–501. 17 indexed citations
16.
17.
Babjuk, M., J Dušková, J Dvořáček, et al.. (2000). Prognostický význam imunohistochemického stanovení p53 ve tkáni povrchových nádorů močového měchýře. 4(2). 20–26.
18.
Novák, Jan. (1997). Flexible iris hooks for phacoemulsification. Journal of Cataract & Refractive Surgery. 23(6). 828–831. 37 indexed citations
19.
Novák, Jan, et al.. (1983). The obturator nerve block. International Urology and Nephrology. 15(2). 149–153. 14 indexed citations
20.
Daynes, Raymond A., Jan Novák, & B C Cole. (1982). Comparison of the cellular requirements for human T cell transformation by a soluble mitogen derived from Mycoplasma arthritidis and concanavalin A.. The Journal of Immunology. 129(3). 936–938. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C A Alper Breakdown of academic impact, for papers by BR Blazar Breakdown of academic impact, for papers by Jean‐Pierre Farcet Breakdown of academic impact, for papers by J Jansen Breakdown of academic impact, for papers by EF Winton Breakdown of academic impact, for papers by Ruud K. B. Schuurman Breakdown of academic impact, for papers by Ming‐Ching Shen Breakdown of academic impact, for papers by J Tanzer Breakdown of academic impact, for papers by Nobuyoshi Arima Breakdown of academic impact, for papers by Nathalie Balandraud
Rankless by CCL
2026